Teva Pharmaceuticals USA, Inc 2024-02-21 Health moderate FDA
Health · FDA · Recall #FDA-D-0321-2024
Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons,… Recall
Issued February 21, 2024 · Teva Pharmaceuticals USA, Inc
In February 2024, Teva Pharmaceuticals USA, Inc recalled the Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons,…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
What you should do
- 1 Stop using Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Teva Pharmaceuticals USA, Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Teva Pharmaceuticals USA, Inc
- Category
- Health
- Recall date
- February 21, 2024
- Units affected
- Not reported
- Sold at
- nationwide
- Recall number
- FDA-D-0321-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Teva Pharmaceuticals USA, Inc has 13 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.